BIGNOTTI, Eliana
 Distribuzione geografica
Continente #
NA - Nord America 2.809
EU - Europa 1.196
AS - Asia 636
SA - Sud America 4
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 4.653
Nazione #
US - Stati Uniti d'America 2.784
PL - Polonia 363
CN - Cina 322
UA - Ucraina 199
IT - Italia 168
DE - Germania 161
SG - Singapore 125
FI - Finlandia 92
HK - Hong Kong 89
GB - Regno Unito 53
EE - Estonia 46
IE - Irlanda 44
TR - Turchia 37
VN - Vietnam 24
CA - Canada 21
SE - Svezia 16
BE - Belgio 14
FR - Francia 14
IN - India 12
CZ - Repubblica Ceca 9
ID - Indonesia 9
NL - Olanda 6
BR - Brasile 4
KR - Corea 4
TW - Taiwan 4
BG - Bulgaria 3
EU - Europa 3
LK - Sri Lanka 3
AU - Australia 2
AZ - Azerbaigian 2
IQ - Iraq 2
KG - Kirghizistan 2
LT - Lituania 2
MU - Mauritius 2
MX - Messico 2
RU - Federazione Russa 2
AT - Austria 1
CR - Costa Rica 1
EG - Egitto 1
HU - Ungheria 1
KZ - Kazakistan 1
LU - Lussemburgo 1
PA - Panama 1
PT - Portogallo 1
Totale 4.653
Città #
Fairfield 408
Warsaw 362
Woodbridge 297
Ashburn 204
Houston 200
Seattle 198
Chandler 194
Jacksonville 146
Cambridge 136
Wilmington 132
Ann Arbor 121
New York 113
Dearborn 109
Singapore 99
Princeton 74
Helsinki 72
Hong Kong 72
Brescia 46
Nanjing 46
Tallinn 46
Dublin 44
Beijing 39
Istanbul 36
Shanghai 35
Los Angeles 27
Dong Ket 24
Jinan 24
Shenyang 21
Milan 20
Nanchang 20
Toronto 19
Kunming 18
San Diego 15
Hebei 14
Brussels 13
Central 13
Des Moines 13
London 13
Changsha 11
Tianjin 11
Monmouth Junction 10
Munich 10
Hangzhou 9
Jakarta 9
Jiaxing 8
Brno 7
Hefei 7
Leawood 7
Ningbo 7
Rome 7
Guangzhou 6
Kilburn 6
Zhengzhou 6
Norwalk 5
Boardman 4
Cazzago San Martino 4
Lancaster 4
Lanzhou 4
Nardò 4
Pune 4
Romola 4
San Francisco 4
Arezzo 3
Augusta 3
Colombo 3
North 3
Parma 3
San Mateo 3
Sofia 3
Taiyuan 3
Taizhou 3
Taoyuan District 3
Verona 3
Washington 3
Baghdad 2
Bagheria 2
Baton Rouge 2
Bishkek 2
Chengdu 2
Cheongju-si 2
Clifton 2
College Station 2
Fort Worth 2
Gunzenhausen 2
Haikou 2
Melbourne 2
Mexico City 2
Olomouc 2
Orange 2
Phoenix 2
Reading 2
Redwood City 2
Roseville 2
Salerno 2
San Bruno 2
South San Francisco 2
Turin 2
Wuhan 2
Xian 2
Almaty 1
Totale 3.728
Nome #
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 288
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients. 264
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD 259
A prognostic regulatory pathway in stage I epithelial ovarian cancer: New hints for the poor prognosis assessment 170
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. 157
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 150
Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients. 149
Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone 147
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 140
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 140
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 140
Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes 139
RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients 132
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 130
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 129
Overexpression of mammaglobin B in epithelial ovarian carcinomas. 127
Genistein affects adipose tissue deposition in a dose-dependent and gender-specific manner. 127
A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer. 123
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 123
Trefoil factor 3: a novel serum marker identified by gene expression profiling in highgrade endometrial carcinomas 122
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 119
Mammaglobin B expression in human endometrial cancer 118
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 117
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 115
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: Implications for personalized cancer therapy 106
LncRNAs as novel indicators of patients' prognosis in stage i epithelial ovarian cancer: A retrospective and multicentric study 98
Claudin-7 expression in human epithelial ovarian cancer 89
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 87
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 77
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 76
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 74
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial 70
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 62
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 61
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 55
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 55
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 48
Integrated mutational landscape analysis of uterine leiomyosarcomas 34
Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes 32
Identification of optimal reference RNAs to normalize miRNA expression data by qRT-PCR in formalin-fixed, paraffin-embedded lymph node tissue 27
Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 27
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy 21
Improved Risk Prediction in Human Papillomavirus-Associated Endocervical Adenocarcinoma Through Assessment of Binary Silva Pattern-based Classification: An International Multicenter Retrospective Observational Study Led by the International Society of Gynecological Pathologists (ISGyP) 19
The Oxford Classic can identify HGSOC patients who may benefit from EMT-targeting therapies 9
Circulating Serum Micro-RNA as Non-Invasive Diagnostic Biomarkers of Endometriosis 1
Totale 4.753
Categoria #
all - tutte 21.682
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.682


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020815 0 0 0 0 80 173 161 125 90 109 27 50
2020/2021758 15 71 11 83 41 78 44 81 75 141 68 50
2021/2022442 64 91 7 3 5 27 28 21 15 59 38 84
2022/2023493 76 32 25 32 47 102 8 52 69 6 24 20
2023/2024619 36 19 64 54 33 165 34 37 80 37 9 51
2024/2025339 22 20 19 201 77 0 0 0 0 0 0 0
Totale 4.753